Caspase-4 Inhibitor Screening via Fluorescence Polarization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Developing caspase-4-specific inhibitors that target the binding of caspase-4 and lipopolysaccharide (LPS) is challenging due to the similarity in substrates among caspases, making it difficult to inhibit caspase-4 activity effectively for treating inflammatory diseases and sepsis.
Innovation Solution
A method involving the use of a mixture containing a polypeptide with a caspase activation and recruitment domain (CARD) labeled with a fluorescent material, where the fluorescence polarization (FP) value is measured to select inhibitors that lower the binding affinity between CARD and LPS, thereby identifying potential therapeutic agents for inflammatory diseases or sepsis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If inhibitors targeting the active site of caspase-4 are developed, then caspase-4 activity can be inhibited, but other caspases are also inhibited due to substrate similarity
Solution Approach 1:
The invention extracts the CARD domain from full-length caspase-4 to create a isolated binding fragment. This allows targeting specifically the LPS binding interface without affecting the catalytic active site, thereby achieving caspase-4 specificity without inhibiting other caspases that share the active site substrate.
Solution Approach 2:
The caspase-4 protein is segmented into functional domains: the CARD domain responsible for LPS binding and the catalytic domain responsible for substrate cleavage. By focusing the inhibitor on the CARD domain's binding interface, the invention achieves selective inhibition of caspase-4's LPS recognition without affecting the catalytic activity shared by other caspases.
2Measurement precision
If a screening method using fluorescent labeling and fluorescence polarization is used, then binding affinity can be measured, but the complexity of the screening system increases
Solution Approach 1:
The CARD domain is labeled with a fluorescent material that exhibits fluorescence polarization changes upon binding to LPS. This optical signal change provides a direct, quantifiable measure of binding affinity, enabling automated high-throughput screening while maintaining measurement precision through fluorescent detection.
Solution Approach 2:
The invention replaces complex mechanical or biochemical assay systems with a fluorescence polarization-based optical measurement system. This substitution simplifies the screening process by using light-based detection to measure binding affinity, reducing the need for complex instrumentation and manual analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the effective screening of inhibitors that specifically inhibit the binding of caspase-4 and LPS, potentially leading to the development of targeted therapeutic agents for inflammatory diseases and sepsis by calculating the inhibition rate and measuring caspase activity in cells.
Implementation Method 1
a polypeptide including a caspase activation and recruitment domain (CARD) labeled with a fluorescent material
Implementation Method 2
measuring a fluorescence polarization (FP) value of the mixture
Data Source
AI summary
Provided are a method of screening an inhibitor of caspase activity by lipopolysaccharide and a method of screening a therapeutic agent for inflammatory diseases or sepsis using the same. Accordingly, it is possible to develop a caspase-4-specific inhibitor.